July 11, 2007- St. Jude Medical Inc. and the Duke Clinical Research Institute (DCRI) announced the first enrollment in a major study designed to better understand appropriate anti-clotting medication therapies for patients following implantation of tissue heart valves.

Medrad Inc. introduced the XDS, a new extravasation detector technology for the Stellant CT Injection System that, for the first time, directly senses extravasation pooling under the skin during a Computed Tomography (CT) procedure, this week at the American Healthcare Radiology Administrators (AHRA) Annual Meeting in Orlando, FL.

July 10, 2007 - CardioVations, a division of Ethicon Inc., a Johnson & Johnson Company, announced the launch of Port Access Precision Series, a new line of surgical instruments for use in minimally invasive valve repair procedures, designed to enhance precision, reliability and control in minimally invasive valve surgery.

July 10, 2007 – The Joint Department of Medical Imaging of the University Health Network (UHN) / Mount Sinai Hospital (MSH) / Women’s College Hospital (WCH), based in Toronto, Ontario, Canada, selected Medrad Inc. as its contract supplier partner for Vascular Injection Systems used in computed tomography (CT), magnetic resonance (MR) and cardiovascular imaging procedures and for MR Patient Monitoring Systems as these facilities strive to enhance cardiac imaging and patient care services.

July 9, 2007- Medtronic Inc. announced the European introduction of the Reveal DX, a new insertable cardiac monitor that offers diagnostic and monitoring information related to syncope (fainting) in patients.

June 9, 2007 - Scivanta Medical Corp. and Ethox International Inc. announced that they entered into an agreement to develop the Hickey Cardiac Monitoring System (HCMS), in which Ethox will provide Scivanta engineering and development support for the catheter component of the HCMS in exchange for the rights to manufacture the component upon regulatory approval and commercialization of the HCMS. The deal with Ethox went into effect on June 29, 2007.

July 9, 2007 - Zerusa Limited and Vascular Solutions Inc. announced that they have entered into a distribution agreement in which Vascular Solutions will distribute Zerusa’s Guardian hemostasis valve, which received 510(k) FDA clearance, to develop market acceptance for the valve in the U.S.
The valve is designed to maintain hemostasis during interventional catheterization procedures through a sealing system, which reportedly allows simple introduction and removal of interventional devices with the option to lock wires in place.

July 9, 2007 - Stereotaxis magnetic navigation systems are being used to guide catheters into the heart for repairs.
A magnetically charged catheter inserted into a patient in their leg uses remarkably powerful magnets to push and pull the catheter into the heart to make repairs. These new magnetic probes are used at Ohio State University Medical Center, one of only 50 hospitals in the world to perform this procedure.

July 9, 2007 – According to The Results for Life Campaign, lab tests for heart attacks enable accurate diagnosis and targeted treatment, resulting in faster, better care for patients suffering from a heart attack by providing physicians with vital information in a matter of minutes.

July 9, 2007 - A study published in the Journal of Nuclear Medicine reports that current PET-CT scanners with standard commercial software designed to provide images of the heart falsely indicated coronary artery disease in as many as 40 percent of 259 patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now